Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07449468Recruiting
Randomised, single-blind trial of ropivacaine in postoperative delirium (POD) (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Incidence of Postoperative Delirium at 72 hours. Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07449468.